Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335)
Cat.#: ACPP-1335
Specifications
Despition Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1837 Rat SCGN Protein (AC1837) 2 µg inquiry ACPP-1535 Human VAMP8 Protein (AC1535) 5 µg inquiry ACPP-1594 Human CCM2 Protein (AC1594) 2 µg inquiry ACPP-1110 Recombinant Human ROR1 Protein (6×His Tag) (AC1110) 50 µg inquiry ACPP-1340 PDE7A Blocking Peptide (AC1340) 250 µg inquiry ACPP-1701 Human SERPINA3 Protein (AC1701) 5 µg inquiry ACPP-1303 Human Stratifin Protein (AC1303) 5 µg inquiry ACPP-1696 Human GHRL Protein (AC1696) 5 µg inquiry ACPP-1422 Human CKB Protein, Pichia (AC1422) 10 µg inquiry ACPP-1068 Adiponectin Blocking Peptide (AC1068) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket